Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

7.52
-0.1730-2.25%
Volume:80.81K
Turnover:611.27K
Market Cap:129.01M
PE:-0.60
High:7.70
Open:7.70
Low:7.42
Close:7.70
52wk High:24.49
52wk Low:7.42
Shares:17.15M
Float Shares:14.99M
Volume Ratio:2.30
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.58
PE(LYR):-0.52

Loading ...

Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Could Be Quite Risky

Simply Wall St.
·
Oct 05

Tonix Pharmaceuticals: Co Intends to Enforce Tonmya Intellectual Property Rights - SEC Filing

THOMSON REUTERS
·
Oct 03

Tonix Pharmaceuticals: Paragraph Iv Certification Challenges Four Tonmya Patents Listed in FDA Orange Book - SEC Filing

THOMSON REUTERS
·
Oct 03

Tonix Says Dr. Reddy’s Files Generic Tonmya Challenge with Paragraph IV Patent Notice

Reuters
·
Oct 03

Tonix announces second major managed Medicare payer agreement for TONMYA

TIPRANKS
·
Sep 22

Tonix Signs Second Managed Medicare Agreement for Tonmya, Adding 21 Million Covered Lives

Reuters
·
Sep 22

Tonix Pharmaceuticals - Tonmya Medicare Coverage NOW Totals 32 Mln Lives in the U.S. (58%)

THOMSON REUTERS
·
Sep 22

Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for Tonmya®

THOMSON REUTERS
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Tonix Pharma (TNXP) and Solventum Corporation (SOLV)

TIPRANKS
·
Sep 15

Tonix Pharmaceuticals Files Form 3 for Chief Commercial Officer Thomas Englese

Reuters
·
Sep 08

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

THOMSON REUTERS
·
Sep 08

Tonix Highlights Tonmya Fibromyalgia Launch, Pipeline Progress in Investor Presentation

Reuters
·
Sep 03

Tonix CEO Seth Lederman Acquires 2,000 Common Shares for $27,580

Reuters
·
Aug 31

Tonix Pharma Director Richard H. Bagger Acquires Common Shares Worth $12,600

Reuters
·
Aug 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 24

Tonix Names CEO Seth Lederman Interim Chief Medical Officer

Reuters
·
Aug 19

Tonix Pharmaceuticals: Stronger-Than-Expected Tonmya Launch, Expanded Market Access, and Advancing Pipeline Underpin Buy Rating

TIPRANKS
·
Aug 11

Tonix Pharmaceuticals price target raised to $27 from $25 at Raymond James

TIPRANKS
·
Aug 11

Tonix Pharmaceuticals Holding Corp. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Tonix Pharmaceuticals reports Q2 EPS ($2.44), consensus ($2.62)

TIPRANKS
·
Aug 10